Accelerate Diagnostics (AXDX) Reports In-Line Q4 EPS

Accelerate Diagnostics (NASDAQ: AXDX) reported Q4 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.87 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• XP Inc. (XP) Tops Q2 EPS by 8c